Mark Altmeyer
Fortune : 213 084 $ au 31/05/2026
Fortune : 213 084 $ au 31/05/2026
Mr. Mark F.
Altmeyer is a Chairman at Calluna Pharma, Inc., an Independent Director at Alector, Inc., a Chairman-Supervisory Board at AM-Pharma BV and a Chief Executive Officer & Director at Arvelle Therapeutics International GmbH.
He is on the Board of Directors at Aculys Pharma LLC, Alector, Inc., Novaremed AG, Arvelle Therapeutics International GmbH and Contact of Mercer County.
Mr. Altmeyer was previously employed as an Independent Director by Clarion Healthcare LLC, a Chief Executive Officer & Executive Director by Arvelle Therapeutics BV, a President & Chief Commercial Officer by Axovant Sciences GmbH, an Independent Director by Myovant Sciences Ltd., a President & Chief Commercial Officer by Axovant Sciences, Inc., a President & Chief Commercial Officer by Axovant Gene Therapies Ltd., a President & Chief Executive Officer by Otsuka America Pharmaceutical, Inc., and a Senior Vice President by Bristol Myers Squibb Co. He also served on the board at Roivant Sciences GmbH.
He received his undergraduate degree from Middlebury College and an MBA from Harvard Business School.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ALECTOR, INC. 0,09% | 17/06/2026 | 98 650 ( 0,09% ) | 213 084 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ALECTOR, INC. | Directeur/Membre du Conseil | 19/03/2024 |
Novaremed AG
Novaremed AG Pharmaceuticals: MajorHealth Technology Develops safer and more efficacious drugs for chronic and life-threatening diseases | Directeur/Membre du Conseil | 01/12/2021 |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology Provides biopharmaceutical products | Président | 06/07/2021 |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Develops and commercializes therapeutic for patients suffering from CNC disorders | Fondateur | 01/01/2019 |
Contact of Mercer County
Contact of Mercer County Miscellaneous Commercial ServicesCommercial Services Provides compassionate, confidential telephone listening and referral services | Directeur/Membre du Conseil | - |
Aculys Pharma LLC
Aculys Pharma LLC BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company focused on neurological diseases | Directeur/Membre du Conseil | 01/04/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
Clarion Healthcare LLC
Clarion Healthcare LLC Miscellaneous Commercial ServicesCommercial Services Operates as life sciences strategy and organizational consulting firm | Independent Dir/Board Member | 01/10/2022 |
Arvelle Therapeutics BV
Arvelle Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Provides medical research services | Fondateur | 01/02/2021 |
| SIO GENE THERAPIES INC. | President | 15/02/2019 |
| ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 17 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Middlebury College
Middlebury College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology Provides biopharmaceutical products | Health Technology |
Novaremed AG
Novaremed AG Pharmaceuticals: MajorHealth Technology Develops safer and more efficacious drugs for chronic and life-threatening diseases | Health Technology |
Alector, Inc.
Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roivant Sciences GmbH
Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Develops and markets biopharmaceutical products | Health Technology |
Sio Gene Therapies, Inc.
Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops gene therapies to treat neurodegenerative diseases | Health Technology |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Myovant Sciences Ltd.
Myovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides women's health and prostate cancer solutions | Health Technology |
Axovant Sciences GmbH
Axovant Sciences GmbH Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which focuses on the treatment of dementia | Health Technology |
Contact of Mercer County
Contact of Mercer County Miscellaneous Commercial ServicesCommercial Services Provides compassionate, confidential telephone listening and referral services | Commercial Services |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Develops and commercializes therapeutic for patients suffering from CNC disorders | Health Technology |
Arvelle Therapeutics BV
Arvelle Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Provides medical research services | Commercial Services |
Clarion Healthcare LLC
Clarion Healthcare LLC Miscellaneous Commercial ServicesCommercial Services Operates as life sciences strategy and organizational consulting firm | Commercial Services |
Aculys Pharma LLC
Aculys Pharma LLC BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company focused on neurological diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national